<DOC>
	<DOCNO>NCT00870311</DOCNO>
	<brief_summary>This study investigate effect Lithium treatment signal transduction pathway , gene expression brain neurochemistry structure patient Bipolar disorder . It hypothesize specific change marker correlate lithium treatment responsiveness .</brief_summary>
	<brief_title>Investigation Lithium Signal Transduction , Gene Expression Brain Myo-Inositol Levels Manic Patients</brief_title>
	<detailed_description>This study investigate effect blind lithium treatment longitudinally patient bipolar disorder . At baseline multiple time point follow initiation lithium treatment 4 week , measure signal transduction pathway , gene expression brain neurochemistry structure obtain . It hypothesize modulation measure predictive lithium treatment responsiveness .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Meet diagnostic criterion Bipolar Mood Disorder determine DSMIV ( SCID ) Meeting criterion DSMIV axis I disorder Psychoactive substance abuse dependence within past 1 year Medical condition place patient increase risk lithium treatment ( include renal disease , hepatic disease , hematological disease ) Devices/implants condition preclude MRI investigation ( include cardiac pacemaker/ICD , aneurysm clip , neurostimulator device , metallic fragment near eye , claustrophobia )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Lithium</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>Neurotrophic</keyword>
	<keyword>bcl2</keyword>
	<keyword>gsk3</keyword>
	<keyword>pkc</keyword>
	<keyword>MRI</keyword>
	<keyword>myoinositol</keyword>
	<keyword>MRS</keyword>
	<keyword>Alzheimers Disease</keyword>
</DOC>